Clinical Trials Directory

Trials / Unknown

UnknownNCT03518918

Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women

Establishing the Diagnosis Standard and Analysis the Risk Factors of Premature Ovarian Insufficiency in Chinese Women: Multi-center, Prospective,Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
50,000 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
Female
Age
12 Years – 39 Years
Healthy volunteers
Not accepted

Summary

The study aims to establishing the diagnosis standard of POI and analyzing the risk factors in Chinese women.

Detailed description

Premature ovarian insufficiency (POI) is a clinical syndrome defined by loss of ovarian activity before the age of 40 years. The POI guideline development group of ESHRE recommends the following diagnostic criteria: oligo/amenorrhea for at least 4 months and an elevated follicle stimulating hormone (FSH) level \>25 mIU/mL on two occasion \>4 weeks apart. But there still no diagnosis standard of POI in Chinese.The study aims to establishing the diagnosis standard of POI and analyzing the risk factors in Chinese women.

Conditions

Timeline

Start date
2016-09-01
Primary completion
2021-09-01
Completion
2021-12-01
First posted
2018-05-08
Last updated
2018-05-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03518918. Inclusion in this directory is not an endorsement.